Rajendra Patel
Family Medicine · Marietta, GANPI 1316940836
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 27.4% of the total. Reporting peaked in 2019 at $1,127 and has fallen 87.5% since, to $141 in 2024.
Across 162 payments — averaging $24.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$714
- Pfizer$428
- Sanofi-aventis U.S. LLC$403
- GSK$365
- Lilly USA, LLC$257
- plus $694 from 14 others
What the payments were for
- Food & beverage$3,918100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $1,077 |
| Novo Nordisk | 44 | $714 |
| Pfizer | 23 | $428 |
| Sanofi-aventis U.S. LLC | 9 | $403 |
| GSK | 9 | $365 |
| Lilly USA, LLC | 17 | $257 |
| AbbVie(2 entities) | 10 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| Amgen | 4 | $52 |
| IBSA Pharma Inc. | 2 | $39 |
| Bayer | 2 | $36 |
| Dexcom, Inc. | 1 | $30 |
| Viiv Healthcare Company | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Optos, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
| Linus Health, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,938 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $119,597 |
| Tresiba Flextouch U-200Insulin Degludec | 35 | $37,586 |
| MounjaroTirzepatide | 12 | $29,219 |
| FarxigaDapagliflozin Propanediol | 19 | $24,172 |
| EliquisApixaban | 17 | $20,166 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $10,291 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,167 |
| Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide | 191 | $4,133 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $3,318 |
| Rosuvastatin Calcium | 339 | $2,689 |
| Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid | 26 | $2,658 |
| Celecoxib | 67 | $2,567 |
| Diclofenac Sodium | 176 | $2,465 |
| Tamsulosin Hcl | 113 | $1,998 |
| Metformin Hcl ErMetformin Hcl | 233 | $1,945 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $714 | $119,59750 claims |
| Lilly USA, LLCMounjaro | $257 | $29,21912 claims |
| AstraZenecaFarxiga | $1,077 | $24,17219 claims |
| PfizerEliquis | $428 | $20,16617 claims |
| GSKTrelegy Ellipta | $365 | $9,16714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Marietta
- Mitzi RubinMarietta$103K
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.